Is Noom Legit? Noom Med's GLP-1 Program, Honestly Reviewed
Noom is one of the best-known names in weight loss, and it now prescribes GLP-1 medication through Noom Med. We checked its licensing, its real Trustpilot record, and every price on its own site — including one figure Noom contradicts itself on — to give you a straight answer.
Medically reviewed by Dr. A. Goher, MD. Sources cited from PubMed & FDA.gov. See our standards
Quick Answer: Is Noom a Legit GLP-1 Provider?
Yes — Noom is a legitimate company and Noom Med is a real, clinician-supervised GLP-1 program that bundles the medication into the plan price. But two things buyers get wrong: its 4.5/5 Trustpilot rating from 66,881 reviews is for the Noom diet app, not the GLP-1 service — there is no separate Noom Med profile — and the plans are billed quarterly in 12-week cycles, not monthly. Verified pricing in August 2026: $179/mo microdose semaglutide, $249/mo full-dose semaglutide, $299/mo tirzepatide — roughly 3.6x the $69/mo charged by Embody for the same molecule. Noom is a reasonable choice if you specifically want its coaching app; it is an expensive one if you just want the medication.
The providers we track and verify
We don't have a commercial relationship with Noom, so we can't monitor its pricing or fulfilment the way we do the programs below. These are the ones we check every week.
The 4.5-Star Rating Is for the App, Not the Medication
This is the single most misleading thing about researching Noom's GLP-1 program. Noom holds a 4.5/5 “Excellent” TrustScore from 66,881 reviews (Trustpilot, verified August 31, 2026) — 60% five-star, 4% one-star. That is a genuinely strong record and Noom has replied to 100% of its negative reviews.
But the profile is noom.com — Noom the diet and coaching app, categorised under Fitness and Nutrition Service and claimed back in November 2017, years before Noom prescribed any medication. A Trustpilot search returns no separate Noom Med profile. The overwhelming majority of those 66,881 reviews are about a calorie-tracking app, not about whether your compounded semaglutide arrived on time and at the right dose.
So treat the 4.5 as evidence that Noom the company is real and responsive — which it is — and not as evidence about the GLP-1 service. Trustpilot also flags on the profile that Noom has no recent history of inviting reviews, so the sample may not be representative of current customers. For comparison, the ratings we publish for providers we track are scored on our own five-pillar methodology, which weighs pricing transparency and pharmacy disclosure — things a general app rating cannot tell you.
What You Actually Get for the Money
Verified on noom.com on August 31, 2026. Noom Med is a bundled program, not a coaching-only subscription with a prescription attached:
- Medication is includedon all three compounded plans — Noom describes them as “all-inclusive pricing: clinical care, medication, and digital program included”, with no separate app subscription stacked on top. The branded-med plan is the sole exception.
- Brand drugs are available too — Noom says it can provide access to Wegovy, Zepbound, Ozempic and Mounjaro, plus oral options including metformin, generic liraglutide and the Wegovy pill. Few compounded-first providers offer both paths.
- Insurance is optional, never required.Noom will work your coverage if you have it; the compounded plans are explicitly labelled “no insurance required”.
- 47 states — not all 50. Noom states the program is unavailable in Alabama, Louisiana and Mississippi. Eligibility starts at a BMI of 25 or higher.
- They do disclose the compounding.Credit where it is due: Noom states plainly that its compounded semaglutide “is produced in an FDA-registered facility but has not been reviewed by the FDA for safety, efficacy, or quality”, and that it has no affiliation with Novo Nordisk or Eli Lilly. Plenty of competitors bury that.
- Clinician detail is thin, though.The site refers to “licensed clinicians” without board certifications, a clinician roster, or an MD/NP breakdown. The only named individual is Chief Medical Officer Dr. Jeffrey Egler. Under our methodology that is a transparency deduction — it is the one area where the better-documented programs we track are clearly ahead.
What Noom Med Customers Actually Report
We read recent threads across r/Noom and r/Semaglutide. Treat these as patterns in self-selected public posts, not as a survey — but the same few themes recur.
The loudest complaint is price opacity: people report that the advertised intro figure does not match what they end up paying, and ask outright what the real all-in monthly number is. That is worth pausing on, because it independently corroborates what we found on Noom's own site — a plan advertised at two different ongoing prices on two pages the same day. When the published numbers disagree, buyer confusion is the predictable result. The second recurring theme is cancellation friction and billing disputes, which predates the GLP-1 business and attaches to Noom's subscription model generally; the quarterly 12-week cycle makes it sharper. Third, some medication customers say the coaching feels automated and that they see in-app ads for supplements and devices while already paying for a bundle whose app they barely open — which matters specifically because the coaching layer is the entire justification for the price premium.
On the positive side, the most consistent praise is for the microdose tier suiting people with roughly 15-30 lb to lose — steady loss with milder side effects than full-dose reports. Users also credit the convenience of the bundle (fast intake-to-approval, shipped medication, direct clinician messaging), and longer-term users do credit the behaviour-change content itself alongside the drug. If the coaching is the thing you actually want, those reports suggest it delivers.
The Regulatory Record
We searched the FDA's public warning-letter database in August 2026 and found no warning letter naming Noom or Noom Med. Read that as a clean public record rather than an endorsement: the database only shows letters the agency has published, and the FDA has issued letters to a number of telehealth firms over how compounded GLP-1s are marketed. The general caution that applies to Noom applies to every compounded provider — these are not FDA-approved finished products (FDA: concerns with unapproved GLP-1 drugs used for weight loss). Noom does disclose a branded pathway (Wegovy, Zepbound, Ozempic) for people who want an FDA-approved product, which not every compounded-only competitor offers.
What Noom Med Actually Costs
Every price below was read directly from noom.com on August 31, 2026. The headline “from $49” figure is an intro price covering your first 4-week supply; the ongoing rate is two-to-four times higher, and it is billed quarterly in 12-week cycles rather than month to month.
Noom Med pricing, verified August 2026
| Plan | What you get | To start | Ongoing | Billed per 12 wks |
|---|---|---|---|---|
| Microdose GLP-1Rx | Compounded semaglutide (low dose) | $49 | $179/mo | $537 |
| GLP-1Rx | Compounded semaglutide (full dose) | $129 | $249/mo | $837 |
| GLP-1Rx Plus | Compounded tirzepatide | $149 | $299/mo | $897 |
| Telehealth for branded meds | Wegovy / Zepbound / Ozempic — medication NOT included | $39 | $129/mo | — |
Compounded plans are all-inclusive (clinical care, medication and the digital program), with no separate Noom app subscription on top. The branded-medication plan is the exception: Noom states the cost of the medication is not included. All plans except Proactive Health are marked FSA/HSA-eligible.
We Found Noom Listing Two Different Prices for the Same Plan
On August 31, 2026 the standard GLP-1Rx plan was advertised at $249/month on Noom's pricing page (noom.com/med/pricing/) and at $279/month — billed as $837per 12 weeks — on that plan's own page (noom.com/med/glp-1rx/). Both were live the same day. The Microdose ($179 = $537/12 weeks) and Plus ($299 = $897/12 weeks) tiers are internally consistent, so this appears to be a stale figure on one of the two pages rather than a deliberate two-tier offer.
It is a $30/month gap — $360 a year — on the plan most Noom Med customers land on. Whichever number is correct, confirm the amount you will actually be billed at checkout before committing to a 12-week cycle.
How Noom Compares on Price to Providers We Track
Noom Med and the cheapest programs we track dispense the same active molecules — compounded semaglutide and compounded tirzepatide — from licensed US compounding pharmacies. The price gap is not a molecule gap.
| Program | Semaglutide | Tirzepatide | Billing | Tracked? |
|---|---|---|---|---|
| Noom Med | $179–$249/mo | $299/mo | Quarterly (12-wk) | No — not verified by us |
| Embody#1 pick | $69/mo | $119/mo | Monthly | Yes |
| SnagRx | $69/mo | $119/mo | Monthly | Yes |
| Bodybuilding.com Health+ | $99/mo | $129/mo | Monthly | Yes |
| Trimi | $99/mo | $125/mo | Monthly | Yes |
| Telos Rx | $99/mo | $139/mo | Monthly | Yes |
Tracked prices verified for the August 31, 2026 snapshot of our GLP-1 Price Index (42 providers; cheapest semaglutide $69, cheapest tirzepatide $119). Noom prices read from noom.com the same day.
In multiples: Noom's microdose plan is about 2.6x the cheapest tracked semaglutide, its full-dose plan about 3.6x, and its tirzepatide plan about 2.5x the cheapest tracked tirzepatide. Over a year, the full-dose gap is roughly $2160.
That premium is not nothing-for-something. Noom's behaviour-change program is the most established product of its kind, and for people who have repeatedly lost and regained weight, structured psychological support alongside the medication is a real argument. The honest framing is that you are buying coaching at a premium, not better medication — the molecules are the same ones studied in STEP-1 (New England Journal of Medicine, 2021, roughly 15% average weight loss on semaglutide) and SURMOUNT-1 (NEJM, 2022, roughly 21% on tirzepatide), whoever dispenses them.
Who Noom Med Suits — and Who It Doesn't
Noom is a reasonable pick if…
- You want structured behaviour-change coaching bundled with the medication, not just a prescription.
- You have regained weight before and think the psychology, not the pharmacology, is your gap.
- You want one all-inclusive bill rather than assembling a provider, a pharmacy and an app.
- You may want a branded route (Wegovy, Zepbound) later and like having both paths under one roof.
Look elsewhere if…
- You mainly want the medication at the lowest defensible price — the gap is 3.6x.
- You need genuine month-to-month flexibility; Noom bills 12 weeks at a time.
- You want a price you can verify in one place before you buy (see the $249-vs-$279 discrepancy above).
- You already have a coaching or accountability system that works for you.
Is Noom Legit? Frequently Asked Questions
Is Noom legit?
Yes. Noom is a legitimate, long-established company — it has operated since 2008, its Trustpilot profile has been claimed since November 2017, and it holds a 4.5/5 rating from 66,881 reviews. Its GLP-1 arm, Noom Med, prescribes through licensed clinicians and bundles the medication into the plan price. The important caveat is scope: that Trustpilot rating covers Noom the diet and coaching app, not the GLP-1 service specifically — there is no separate Noom Med profile on Trustpilot — so it is not evidence about the medication side of the business.
How much does Noom's GLP-1 program cost?
Noom Med runs $179-$299/month depending on the plan, after a lower first-month intro price, and it is billed quarterly in 12-week cycles rather than monthly. Verified on noom.com in August 2026: Microdose GLP-1Rx (low-dose compounded semaglutide) $49 to start then $179/mo, billed $537 per 12 weeks; GLP-1Rx (full-dose compounded semaglutide) $129 to start then $249/mo, billed $837 per 12 weeks; GLP-1Rx Plus (compounded tirzepatide) $149 to start then $299/mo, billed $897 per 12 weeks. A separate telehealth-only plan for branded Wegovy or Zepbound is $39 then $129/mo and does not include the cost of the medication.
Does Noom Med include the medication in the price?
Yes for the compounded plans. Noom describes its Microdose GLP-1Rx, GLP-1Rx and GLP-1Rx Plus plans as all-inclusive: clinical care, medication, and the digital program in one price, with no separate Noom app subscription stacked on top. The one exception is the branded-medication telehealth plan at $129/month, where Noom states plainly that the cost of the medication is not included — you pay for Wegovy or Zepbound separately, whether through insurance or cash.
Is Noom cheaper than other GLP-1 providers?
No. Noom is one of the more expensive routes to the same molecule. Its cheapest compounded semaglutide plan is $179/month and its full-dose plan is $249/month, against $69/month from Embody — roughly 3.6x more for the full-dose plan. Compounded tirzepatide is $299/month at Noom versus $119/month at the cheapest tracked provider. The premium buys Noom's behaviour-change coaching app, which is the real product and genuinely differentiated; it does not buy a different or better molecule.
Why does Noom list two different prices for the same plan?
We found a genuine inconsistency on Noom's own site in August 2026: the GLP-1Rx plan is priced at $249/month on noom.com/med/pricing/ but at $279/month (billed as $837 per 12 weeks) on the plan's own page at noom.com/med/glp-1rx/. Both were live on the same day. The Microdose and Plus tiers are internally consistent. Until Noom reconciles them, confirm the figure you will actually be billed at checkout rather than relying on the advertised monthly number.
What states is Noom Med available in?
Noom Med operates in 47 states. Noom states the program is currently available in all US states except Alabama, Louisiana and Mississippi. Eligibility starts at a BMI of 25 or higher, and insurance is optional rather than required — the compounded plans are labelled "no insurance required", and Noom will work with your coverage if you have it.
Can you cancel Noom Med anytime?
Noom's plan pages say "cancel anytime", but the billing structure matters more than the phrase. Because the compounded plans bill quarterly in 12-week cycles, cancelling part-way through a cycle does not refund the remainder of that cycle — you have already paid $537 to $897 up front. Practically, the shortest commitment is 12 weeks, not one month. If you want a genuinely month-to-month arrangement, a flat-priced monthly provider is a better structural fit.
Is Noom Med's compounded semaglutide FDA-approved?
No, and this is true of every compounded GLP-1, not just Noom's. Compounded semaglutide and tirzepatide are prepared by compounding pharmacies and are not FDA-approved finished products, so they have not been through the agency's review for that specific formulation. The FDA has published general concerns about unapproved GLP-1 drugs sold for weight loss. Noom also offers a branded pathway (Wegovy, Zepbound, Ozempic) if you want an FDA-approved product and can access it through insurance.
Has Noom received an FDA warning letter?
We searched the FDA's public warning-letter database in August 2026 and found no warning letter naming Noom or Noom Med. That is a check on the public record rather than a guarantee — the database only reflects letters the FDA has published, and absence of a letter is not an endorsement. Separately, the FDA has issued warning letters to a number of telehealth companies over how compounded GLP-1s are marketed, so it is worth re-checking the database yourself before signing up with any provider, Noom included.
Want the Same Molecule for Less?
Embody dispenses the same compounded semaglutide from $69/month, billed monthly, with no 12-week commitment.
Disclaimer: Educational content, not medical advice. GLP-1 medications are prescription drugs; eligibility and dosing are decided by a licensed prescriber. Compounded medications are not FDA-approved finished products. GLP-1 Watchdog has no commercial relationship with Noom and does not earn a commission from them; we do earn commission from the tracked providers listed above, which never affects our scoring — see our methodology and affiliate disclosure. Prices verified August 31, 2026 and change often.